Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

AKYA

Akoya Biosciences Inc

Oct 17 • 04:00PM ET

3.06

Dollar change -0.14
Percentage change -4.38	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: ILMN PACB TWST NTLA CRSP EXAS CDNA GH FATE TXG

| Held by: VTI IWM VXF IWO VTWO VHT IWC VTWG RSSL UWM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.23	Insider Own	55.32%	Shs Outstand	49.12M	Perf Week	5.88%
Market Cap	151.47M	Forward P/E	-	EPS next Y	-0.55	Insider Trans	-0.05%	Shs Float	22.11M	Perf Month	7.75%
Income	-60.35M	PEG	-	EPS next Q	-0.20	Inst Own	25.28%	Short Float	10.66%	Perf Quarter	29.66%
Sales	93.22M	P/S	1.62	EPS this Y	29.24%	Inst Trans	-23.33%	Short Ratio	15.03	Perf Half Y	-20.52%
Book/sh	0.45	P/B	6.80	EPS next Y	46.01%	ROA	-36.29%	Short Interest	2.36M	Perf Year	-17.30%
Cash/sh	0.91	P/C	3.35	EPS next 5Y	-	ROE	-128.20%	52W Range	1.88 - 6.31	Perf YTD	-37.30%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-37.60%	ROI	-58.24%	52W High	-51.51%	Beta	1.37
Dividend TTM	-	Quick Ratio	1.98	Sales past 5Y	23.82%	Gross Margin	53.01%	52W Low	62.77%	ATR (14)	0.20
Dividend Ex-Date	-	Current Ratio	2.73	EPS Y/Y TTM	37.72%	Oper. Margin	-51.65%	RSI (14)	55.81	Volatility	6.47% 6.70%
Employees	330	Debt/Eq	3.81	Sales Y/Y TTM	9.66%	Profit Margin	-64.74%	Recom	2.00	Target Price	5.00
Option/Short	Yes / Yes	LT Debt/Eq	3.66	EPS Q/Q	48.02%	Payout	-	Rel Volume	0.83	Prev Close	3.20
Sales Surprise	-1.13%	EPS Surprise	-1.35%	Sales Q/Q	-1.52%	Earnings	Aug 05 AMC	Avg Volume	156.78K	Price	3.06
SMA20	5.27%	SMA50	15.04%	SMA200	-13.54%	Trades		Volume	129,553	Change	-4.38%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-06-24	Downgrade	JP Morgan	Overweight → Neutral
Aug-06-24	Downgrade	BTIG Research	Buy → Neutral
Jun-21-24	Initiated	Craig Hallum	Buy	$7.50
Dec-14-23	Initiated	Guggenheim	Neutral
Jul-05-23	Resumed	JP Morgan	Overweight	$18
Feb-02-23	Initiated	UBS	Buy	$14
Nov-03-22	Initiated	CapitalOne	Overweight	$19
Oct-06-22	Initiated	Stephens	Overweight	$16
Jun-22-22	Initiated	BTIG Research	Buy	$16
Jan-06-22	Resumed	Piper Sandler	Overweight	$23
May-11-21	Initiated	Piper Sandler	Overweight	$28
May-11-21	Initiated	Morgan Stanley	Overweight	$26
May-11-21	Initiated	JP Morgan	Overweight	$23
May-11-21	Initiated	Canaccord Genuity	Buy	$25

Show Previous Ratings

Oct-07-24 08:00AM	Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy (GlobeNewswire) +15.47%
Oct-03-24 04:00PM	Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors (GlobeNewswire) +8.81%
Aug-05-24 08:59PM	AKYA Stock Earnings: Akoya Biosciences Meets EPS, Misses Revenue for Q2 2024 (InvestorPlace) -6.51%
05:10PM	Akoya Biosciences (AKYA) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:07PM	Akoya: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Loading…
04:00PM	Akoya Biosciences Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-15-24 04:00PM	Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences (GlobeNewswire) +13.30%
May-15-24 08:02AM	Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating (MT Newswires)
May-14-24 01:55PM	Top Midday Decliners (MT Newswires) -29.61%
09:01AM	Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
08:14AM	Top Premarket Decliners (MT Newswires)
07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-13-24 08:54PM	AKYA Stock Earnings: Akoya Biosciences Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:35PM	Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:36PM	Akoya: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Loading…
04:00PM	Akoya Biosciences Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-09-24 08:00AM	Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients (GlobeNewswire) +9.00%
May-06-24 10:00AM	Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
08:00AM	Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts (GlobeNewswire)
May-02-24 08:00AM	Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows (GlobeNewswire)
Apr-22-24 04:05PM	Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024 (GlobeNewswire)
Apr-05-24 08:00AM	Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale (GlobeNewswire)
Mar-05-24 09:52AM	Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript (Insider Monkey) -14.72%
07:00AM	Q4 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-04-24 08:51PM	AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
05:31PM	Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook (GuruFocus.com)
05:15PM	Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:21PM	Akoya: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook (GlobeNewswire)
Feb-08-24 04:05PM	Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference (GlobeNewswire)
04:13AM	Loading…
Feb-07-24 04:13AM	Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength? (Zacks)
Jan-18-24 08:00AM	Akoya Biosciences' Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases (GlobeNewswire)
Jan-10-24 08:00AM	Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board (GlobeNewswire)
Jan-08-24 01:07AM	Akoya Biosciences Issues Preliminary Revenue Results; Issues 2024 Guidance (RTT News) +20.09%
Jan-07-24 08:00AM	Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform (GlobeNewswire)
08:00AM	Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook (GlobeNewswire)
08:00AM	Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow (GlobeNewswire)
Jan-05-24 08:34AM	How Akoya Biosciences (AKYA) Stock Stands Out in a Strong Industry (Zacks)
Dec-27-23 09:55AM	How Much Upside is Left in Akoya (AKYA)? Wall Street Analysts Think 86% (Zacks)
Dec-20-23 08:05AM	Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-12-23 10:51AM	Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 10:25AM	Q3 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) +10.90%
Nov-08-23 05:51PM	Akoya Biosciences Inc (AKYA) Reports 34% Year-Over-Year Revenue Growth in Q3 2023 (GuruFocus.com)
04:05PM	Akoya: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance (GlobeNewswire)
Nov-02-23 08:00AM	Akoya to Participate at Three Upcoming Investor Conferences (GlobeNewswire) +7.92%
Nov-01-23 10:01AM	Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-31-23 09:00AM	Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023 (GlobeNewswire)
Oct-17-23 10:22AM	Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures (GlobeNewswire) +5.41%
Oct-11-23 04:05PM	Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023 (GlobeNewswire) -8.21% -6.10%
Sep-19-23 08:00AM	Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms (GlobeNewswire)
Aug-17-23 09:56AM	10 Healthcare Stocks with Insider Buying (Insider Monkey)
Aug-08-23 12:38PM	Q2 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 06:15PM	Akoya Biosciences (AKYA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Akoya: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance (GlobeNewswire)
08:05AM	Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies (GlobeNewswire)
Aug-06-23 10:57AM	Private equity firms account for 49% of Akoya Biosciences, Inc.'s (NASDAQ:AKYA) ownership, while institutions account for 29% (Simply Wall St.)
Jul-26-23 04:05PM	Akoya to Participate at Three Upcoming Investor Conferences (GlobeNewswire)
Jul-21-23 09:21AM	Emergent's (EBS) Cyfendus Anthrax Vaccine Gets FDA Nod (Zacks)
Jul-12-23 09:55AM	Can Akoya (AKYA) Climb 116.14% to Reach the Level Wall Street Analysts Expect? (Zacks)
08:05AM	Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023 (GlobeNewswire)
Jul-10-23 10:08AM	The past year for Akoya Biosciences (NASDAQ:AKYA) investors has not been profitable (Simply Wall St.) +5.47%
Jun-13-23 07:58PM	Insiders Pour Millions Into These 2 Stocks, J.P. Morgan Says They Have up to 175% Upside Heres Why You Should Pay Attention (TipRanks) +20.40% +16.79%
12:32PM	Why Shares of Akoya Biosciences Jumped on Tuesday (Motley Fool)
08:29AM	Independent Director of Akoya Biosciences Picks Up 26% More Stock \ (Simply Wall St.)
06:37AM	Daily Vickers Top Buyers & Sellers for 06/13/2023 (Argus Research)
Jun-12-23 04:05PM	Akoya to Participate at Two Upcoming Investor Conferences (GlobeNewswire)
Jun-08-23 12:55AM	Akoya Biosciences Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -5.04%
Jun-07-23 04:08PM	Akoya Biosciences Announces Public Offering of Common Stock (GlobeNewswire)
May-09-23 10:43AM	Q1 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-08-23 05:35PM	Akoya Biosciences (AKYA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.99%
04:32PM	Akoya: Q1 Earnings Snapshot (AP Finance)
04:05PM	Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance (GlobeNewswire)
May-05-23 07:36AM	Is Akoya Biosciences, Inc. (NASDAQ:AKYA) Trading At A 34% Discount? (Simply Wall St.)
Apr-27-23 08:00AM	Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument (GlobeNewswire)
Apr-17-23 12:20PM	A Piece Of The Puzzle Missing From Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Share Price (Simply Wall St.) +6.53%
Apr-14-23 03:38PM	Down More Than 50%: These 2 Strong Buy Stocks Are Flirting With a Bottom (TipRanks)
Apr-12-23 08:00AM	Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow (GlobeNewswire) -6.48%
08:00AM	Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data (GlobeNewswire)
Apr-06-23 08:00AM	Akoya to Report First Quarter 2023 Financial Results on May 8th, 2023 (GlobeNewswire)
Mar-20-23 04:00PM	Akoya Biosciences Announces Leadership Transition (GlobeNewswire) -5.47% +8.68%
Mar-09-23 05:17AM	Akoya Biosciences Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Mar-08-23 07:21AM	Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 09:52AM	Q4 2022 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-06-23 05:35PM	Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -5.11%
04:05PM	Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance (GlobeNewswire)
Feb-28-23 08:00AM	Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel (GlobeNewswire) -5.41%
Feb-27-23 10:00AM	Will Akoya Biosciences (AKYA) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-10-23 06:36PM	Argo Group and Akoya Biosciences Stock See Action From Activist Investors (Barrons.com)
Feb-06-23 08:05AM	Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences (GlobeNewswire)
Feb-01-23 08:00AM	Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting (GlobeNewswire)
Jan-08-23 04:00PM	Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022 (GlobeNewswire)
Jan-06-23 08:00AM	Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications (Business Wire) +9.48%
Dec-28-22 04:00PM	Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +10.47%
Dec-15-22 04:00PM	Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day (GlobeNewswire)
Dec-07-22 05:15AM	Institutions own 23% of Akoya Biosciences, Inc. (NASDAQ:AKYA) shares but private equity firms control 49% of the company (Simply Wall St.)
Nov-07-22 05:25PM	Akoya Biosciences (AKYA) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -5.86% -9.76%
04:05PM	Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance (GlobeNewswire)
04:05PM	Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy (GlobeNewswire)

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McKelligon Brian	President and CEO	Jun 11 '24	Option Exercise	0.30	7,500	2,272	232,233	Jun 12 04:01 PM
McKelligon Brian	President and CEO	Jun 11 '24	Sale	2.08	7,500	15,630	224,733	Jun 12 04:01 PM
McKelligon Brian	President and CEO	Jun 06 '24	Option Exercise	0.30	7,500	2,272	232,233	Jun 07 09:56 PM
McKelligon Brian	President and CEO	Jun 06 '24	Sale	2.01	7,500	15,064	224,733	Jun 07 09:56 PM
McKelligon Brian	President and CEO	Mar 20 '24	Option Exercise	0.30	7,500	2,272	239,368	Mar 22 05:54 PM
McKelligon Brian	President and CEO	Mar 20 '24	Sale	4.97	7,500	37,243	231,868	Mar 22 05:54 PM
McKelligon Brian	President and CEO	Mar 13 '24	Sale	4.94	7,500	37,035	224,368	Mar 14 08:41 PM
McKelligon Brian	President and CEO	Dec 19 '23	Option Exercise	0.30	7,500	2,272	160,063	Dec 20 07:16 PM
McKelligon Brian	President and CEO	Dec 19 '23	Sale	4.48	7,500	33,566	152,563	Dec 20 07:16 PM
McKelligon Brian	President and CEO	Dec 12 '23	Option Exercise	0.30	7,500	2,272	160,063	Dec 14 04:24 PM
McKelligon Brian	President and CEO	Dec 12 '23	Sale	4.25	7,500	31,871	152,563	Dec 14 04:24 PM
McKelligon Brian	President and CEO	Nov 20 '23	Option Exercise	0.30	7,500	2,272	160,063	Nov 22 04:00 PM
McKelligon Brian	President and CEO	Nov 20 '23	Sale	4.39	7,500	32,901	152,563	Nov 22 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AKYA

Akoya Biosciences Inc

Upgrade your FINVIZ experience